Position in ALKS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,030,885
New position
Shares Held
29,154
first reported quarter
Ownership
0.017%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ALLSTATE CORP holds $15,014,275 across 8 Drug Manufacturers - Specialty & Generic names. ALKS ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
45,809 | $5,415,081 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
4,710 | $2,792,935 | |
| 3 | VTRS |
Viatris Inc
|
153,602 | $2,075,163 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
12,349 | $1,626,857 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
60,074 | $1,437,570 | |
| 6 | ALKS |
Alkermes plc.
This page
|
29,154 | $1,030,885 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
56,727 | $367,023 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
21,622 | $268,761 |
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,030,885 | 29,154 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||